One-year outcomes of the U.S. and Japanese regulatory trial of the Misago stent for treatment of superficial femoral artery disease (OSPREY study)

Journal of Vascular Surgery

Volumn 63, Issue 2, 2016, Pages 370-376.e1

  Ohki, Takao ^a,g   Angle, John F ^b   Yokoi, Hiroyoshi ^c   Jaff, Michael R ^d   Popma, Jeffrey ^e   Piegari, Guy ^f   Kanaoka, Yuji ^a   Feiring, Andrew ^h   Nelson, Brian ^h   Glickman, Marc ^h   Guimaraes, Marcelo ^h   Hall, Patrick ^h   Johnson, Sarah ^h   Jordan, William ^h   Khoudoud, Omran ^h   Leung, Daniel ^h   McGarvey, Joseph ^h   McKinsey, James ^h   Nowygrod, Roman ^h   Shammas, Nicolas ^h   Carey, Daniel ^h   Iyengar, Srinivas ^h   Isenbarger, Daniel ^h   Ali, Vaqar ^h   Ashchi, Majdi ^h   Rivera, Ernesto ^h   Moursi, Mohammed ^h   Bachinsky, William ^h   Metzger, Christopher ^h   Aronow, Herbert ^h   Wiechmann, Bret ^h   Callicutt, Christopher ^h   Gordon, Ian ^h   Chaille, Peter ^h   Espinoza, Andrey ^h   Foster, Malcolm ^h   Sharafuddin, Mel ^h   Shah, Rakesh ^h   Bunch, Frank ^h   Harlin, Stuart ^h   Iwabuchi, Masashi ^h   Ando, Kenji ^h   Kichikawa, Kimihiko ^h   Muramatsu, Toshiya ^h   Urasawa, Kazushi ^h   Yokoi, Yoshiaki ^h   Uematsu, Masaaki ^h   Lo, Ping Han ^h   Huang, Chi Hung ^h   Kao, Hsien Li ^h   Jae, Hwanjun ^h   more..

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c FUKUOKA SANNO HOSPITAL   (Japan)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^f Berks Cardiologists   (United States)

^g JIKEI UNIVERSITY HOSPITAL   (Japan)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTERY DISEASE; ASIAN; BLACK PERSON; CONFERENCE PAPER; DEVICE SAFETY; DEVICE THERAPY; FEMALE; HISPANIC; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE DIFFERENCE; REVASCULARIZATION; SELF EXPANDING NITINOL STENT; SOUTH KOREA; STENT FRACTURE; STENT THROMBOSIS; SUPERFICIAL FEMORAL ARTERY DISEASE; TAIWAN; TREATMENT OUTCOME; UNITED STATES; VASCULAR PATENCY; ADVERSE EFFECTS; CLINICAL TRIAL; COMPARATIVE STUDY; DEVICES; ENDOVASCULAR SURGERY; EPIDEMIOLOGY; ETHNOLOGY; FEMORAL ARTERY; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PERIPHERAL ARTERIAL DISEASE; PROSTHESIS DESIGN; PROSTHESIS FAILURE; RISK FACTOR; STENOSIS, OCCLUSION AND OBSTRUCTION; STENT; THROMBOSIS; TIME FACTOR;

AGED; CONSTRICTION, PATHOLOGIC; ENDOVASCULAR PROCEDURES; FEMALE; FEMORAL ARTERY; HUMANS; JAPAN; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; PROSTHESIS FAILURE; REPUBLIC OF KOREA; RISK FACTORS; STENTS; TAIWAN; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; VASCULAR PATENCY;

EID: 84957435506     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2015.08.093     Document Type: Conference Paper

References (20)

1. L. Norgren, W.R. Hiatt, J.A. Dormandy, M.R. Nehler, K.A. Harris, F.G. Fowkes, and et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) Eur J Vasc Endovasc Surg 33 2007 S1 S75
2. M. Jaff, M. Dake, J. Pompa, G. Ansel, and T. Yoder Standardized evaluation and reporting of stent fractures in clinical trials of noncoronary devices Catheter Cardiovasc Interv 70 2007 460 462
3. D. Scheinert, S. Scheinert, J. Sax, C. Piorkowski, S. Bräunlich, M. Ulrich, and et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting J Am Coll Cardiol 45 2005 312 315
4. O. Schlager, P. Dick, S. Sabeti, J. Amighi, W. Mlekusch, E. Minar, and et al. Long-segment SFA stenting - the dark sides: in-stent restenosis, clinical deterioration, and stent fractures J Endovasc Ther 12 2005 676 684
5. H.Q. Zhao, A. Nikanorov, R. Virmani, R. Jones, E. Pacheco, and L.B. Schwartz Late stent expansion and neointimal proliferation of oversized nitinol stents in peripheral arteries Cardiovasc Intervent Radiol 32 2009 720 726
6. S.K. Yazdani, and J.L. Berry Development of an in vitro system to assess stent-induced smooth muscle cell proliferation: a feasibility study J Vasc Interv Radiol 20 2009 101 106
7. S. Müller-Hülsbeck, P.J. Schäfer, N. Charalambous, H. Yagi, M. Heller, and T. Jahnke Comparison of second-generation stents for application in the superficial femoral artery: an in vitro evaluation focusing on stent design J Endovasc Ther 17 2010 767 776
8. K.L. Schulte, S. Müller-Hülsbeck, P. Cao, J.P. Becquemin, R. Langhoff, N. Charalambous, and et al. MISAGO 1: first-in-man clinical trial with Misago nitinol stent EuroIntervention 5 2010 687 691
9. K.L. Schulte, I. Kralj, H.M. Gissler, L.A. Bagnaschino, I. Buschmann, J.M. Pernès, and et al. MISAGO 2: one-year outcomes after implantation of the Misago self-expanding nitinol stent in the superficial femoral and popliteal arteries of 744 patients J Endovasc Ther 19 2012 774 784
10. I. Kralj, I. Boos, and U. Müller-Bühl Three year results of endovascular therapy with a new generation nitinol stent for femoro-popliteal artery lesions - a single-center outcome analysis of a subcohort of MISAGO 2 study Vasa 42 2013 340 349
11. S.H. Duda, M. Bosiers, J. Lammer, D. Scheinert, T. Zeller, V. Oliva, and et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial J Endovasc Ther 13 2006 701 710
12. H. Krankenberg, M. Schluter, H.J. Steinkamp, K. Bürgelin, D. Scheinert, K.L. Schulte, and et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST) Circulation 116 2007 285 292
13. W.A. Gray, A. Feiring, M. Cioppi, R. Hibbard, B. Gray, Y. Khatib, and et al. S.M.A.R.T. self-expanding nitinol stent for the treatment of atherosclerotic lesions in the superficial femoral artery (STROLL): 1-year outcomes J Vasc Interv Radiol 26 2015 21 28
14. J.R. Laird, A. Jain, T. Zeller, R. Feldman, D. Scheinert, J.J. Popma, and et al. Nitinol stent implantation in the superficial femoral artery and proximal popliteal artery: twelve-month results from the complete SE multicenter trial J Endovasc Ther 21 2014 202 212
15. M.D. Dake, G.M. Ansel, M.R. Jaff, T. Ohki, R.R. Saxon, H.B. Smouse, and et al. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease twelve-month Zilver PTX randomized study results Circ Cardiovasc Interv 4 2011 495 504
16. A.V. Finn, M. Joner, G. Nakazawa, F. Kolodgie, J. Newell, M.C. John, and et al. Pathological correlates of late drug-eluting stent thrombosis strut coverage as a marker of endothelialization Circulation 115 2007 2435 2441
17. T. Ishihara, O. Iida, M. Awata, K. Nanto, S. Nanto, and M. Uematsu Angioscopic assessment of early phase arterial repair after paclitaxel-coated nitinol drug-eluting stent implantation in the superficial femoral artery Circ J 77 2013 1838 1843
18. T. Ishihara, O. Iida, M. Awata, T. Shiraki, S. Nanto, and M. Uematsu Angioscopically apparent large thrombus and uncovered stent struts 6 months after late stent thrombosis of a paclitaxel-coated nitinol drug-eluting stent implanted in the superficial femoral artery Cardiovasc Interv Ther 29 2014 82 85
19. T.J. Chong, V.L. Rowe, F.A. Weaver, and S.G. Katz Impact of race on infrainguinal angioplasty and stenting Ann Vasc Surg 25 2011 204 209
20. T. Ohki, H. Yokoi, K. Kichikawa, T. Kimura, S.A. Snyder, A.O. Ragheb, and et al. Two-year analysis of the Japanese cohort from the Zilver PTX randomized controlled trial supports the validity of multinational clinical trials J Endovasc Ther 21 2014 644 653